{"id":1360,"date":"2009-11-18T23:27:32","date_gmt":"2009-11-19T04:27:32","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/at-the-aha%c2%a0new-and-updated-results-from-bari-2d\/"},"modified":"2011-07-19T17:45:07","modified_gmt":"2011-07-19T21:45:07","slug":"at-the-aha%c2%a0new-and-updated-results-from-bari-2d","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2009\/11\/18\/at-the-aha%c2%a0new-and-updated-results-from-bari-2d\/","title":{"rendered":"At the AHA:\u00a0New and Updated Results from BARI 2D"},"content":{"rendered":"<p>During\u00a0complementary presentations at the\u00a0AHA, investigators provided new and updated study data from the <a href=\"http:\/\/cardioexchange.org\/nejm\/content\/full\/360\/24\/2503?searchTerm=BARI+2D\">BARI 2D trial<\/a>.<\/p>\n<p>Dr. Bernard Chaitman reported on findings regarding the secondary endpoints of cardiac death and myocardial infarction.\u00a0 These findings suggest that patients similar to those in the PCI stratum benefit more from intensive medical therapy alone.\u00a0 In contrast, patients with more extensive coronary disease, similar to those in the CABG stratum, benefited more from prompt revascularization\u00a0via\u00a0CABG along with intensive medical therapy and\u00a0insulin sensitizing therapy.<\/p>\n<p>Dr. Mark Hlatky reported results of a cost-effectiveness analysis suggesting that prompt revascularization overall increases cost among patients with type 2 diabetes and stable coronary disease.\u00a0 In particular, intensive medical therapy with delayed revascularization, as needed, is more cost-effective and preferred for patients similar to those in the PCI arm.<\/p>\n<p>The main findings of both the\u00a0<a href=\"http:\/\/circ.ahajournals.org\/cgi\/content\/abstract\/CIRCULATIONAHA.109.913111v1\">secondary\u00a0endpoints<\/a> and <a href=\"http:\/\/circ.ahajournals.org\/cgi\/content\/abstract\/CIRCULATIONAHA.109.912709v1\">cost-effectiveness <\/a>studies were published ahead of print in <em>Circulation<\/em>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>During\u00a0complementary presentations at the\u00a0AHA, investigators provided new and updated study data from the BARI 2D trial. Dr. Bernard Chaitman reported on findings regarding the secondary endpoints of cardiac death and myocardial infarction.\u00a0 These findings suggest that patients similar to those in the PCI stratum benefit more from intensive medical therapy alone.\u00a0 In contrast, patients with [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1360","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=1360"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/1360\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=1360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=1360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=1360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}